Titre : bêta-Alanine

bêta-Alanine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Warehousing
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "bêta-Alanine : Questions médicales les plus fréquentes", "headline": "bêta-Alanine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les bêta-Alanine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-16", "dateModified": "2025-03-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "bêta-Alanine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Alanine", "url": "https://questionsmedicales.fr/mesh/D000409", "about": { "@type": "MedicalCondition", "name": "Alanine", "code": { "@type": "MedicalCode", "code": "D000409", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.125.042" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acide pantothénique", "alternateName": "Pantothenic Acid", "url": "https://questionsmedicales.fr/mesh/D010205", "about": { "@type": "MedicalCondition", "name": "Acide pantothénique", "code": { "@type": "MedicalCode", "code": "D010205", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.125.042.070.500" } } } ], "about": { "@type": "MedicalCondition", "name": "bêta-Alanine", "alternateName": "beta-Alanine", "code": { "@type": "MedicalCode", "code": "D015091", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Bryan Saunders", "url": "https://questionsmedicales.fr/author/Bryan%20Saunders", "affiliation": { "@type": "Organization", "name": "Applied Physiology and Nutrition Research Group, Rheumatology Division, Faculdade de Medicina FMUSP, School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "Eimear Dolan", "url": "https://questionsmedicales.fr/author/Eimear%20Dolan", "affiliation": { "@type": "Organization", "name": "Applied Physiology and Nutrition Research Group, Rheumatology Division, Faculdade de Medicina FMUSP, School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "Bruno Gualano", "url": "https://questionsmedicales.fr/author/Bruno%20Gualano", "affiliation": { "@type": "Organization", "name": "Applied Physiology and Nutrition Research Group, School of Physical Education and Sport; Rheumatology Division; Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, SP, BR, University of São Paulo, Brazil." } }, { "@type": "Person", "name": "Marcelo Papoti", "url": "https://questionsmedicales.fr/author/Marcelo%20Papoti", "affiliation": { "@type": "Organization", "name": "University of São Paulo, Medicine University of Ribeirão Preto (FMRP-USP), Ribeirão Preto, São Paulo, Brazil." } }, { "@type": "Person", "name": "Craig Sale", "url": "https://questionsmedicales.fr/author/Craig%20Sale", "affiliation": { "@type": "Organization", "name": "Musculoskeletal Physiology Research Group, Sport, Health and Performance Enhancement Research Centre, Nottingham Trent University, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "FHIR-Ontop-OMOP: Building clinical knowledge graphs in FHIR RDF with the OMOP Common data Model.", "datePublished": "2022-09-09", "url": "https://questionsmedicales.fr/article/36089199", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbi.2022.104201" } }, { "@type": "ScholarlyArticle", "name": "Opportunities and Obstacles to the Development of Health Data Warehouses in Hospitals in France: The Recent Experience of Comprehensive Cancer Centers.", "datePublished": "2023-01-16", "url": "https://questionsmedicales.fr/article/36674399", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20021645" } }, { "@type": "ScholarlyArticle", "name": "A Clinical Data Warehouse Analysis of Risk Factors for Inpatient Falls in a Tertiary Hospital: A Case-Control Study.", "datePublished": "2023-09-15", "url": "https://questionsmedicales.fr/article/37712829", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/PTS.0000000000001163" } }, { "@type": "ScholarlyArticle", "name": "Dental developmental complications in pediatric hematopoietic stem cell transplantation patients: A study using CMC clinical data warehouse.", "datePublished": "2022-12-22", "url": "https://questionsmedicales.fr/article/36548286", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0279579" } }, { "@type": "ScholarlyArticle", "name": "Leveraging electronic medical records for HIV testing, care, and treatment programming in Kenya-the national data warehouse project.", "datePublished": "2023-09-15", "url": "https://questionsmedicales.fr/article/37715195", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12911-023-02265-6" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Acides aminés", "item": "https://questionsmedicales.fr/mesh/D000596" }, { "@type": "ListItem", "position": 4, "name": "Alanine", "item": "https://questionsmedicales.fr/mesh/D000409" }, { "@type": "ListItem", "position": 5, "name": "bêta-Alanine", "item": "https://questionsmedicales.fr/mesh/D015091" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : bêta-Alanine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur bêta-Alanine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur bêta-Alanine", "description": "Comment diagnostiquer une carence en bêta-alanine ?\nQuels tests peuvent évaluer les niveaux de bêta-alanine ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Data+Warehousing&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur bêta-Alanine", "description": "Quels sont les symptômes d'une supplémentation excessive en bêta-alanine ?\nLa bêta-alanine cause-t-elle des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Data+Warehousing&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur bêta-Alanine", "description": "Comment prévenir une carence en bêta-alanine ?\nLes sportifs doivent-ils se supplémenter en bêta-alanine ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Data+Warehousing&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur bêta-Alanine", "description": "La bêta-alanine est-elle utilisée pour traiter des maladies ?\nComment la bêta-alanine améliore-t-elle la performance ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Data+Warehousing&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur bêta-Alanine", "description": "Quelles complications peuvent survenir avec une surconsommation ?\nLa bêta-alanine peut-elle interagir avec d'autres médicaments ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Data+Warehousing&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur bêta-Alanine", "description": "Qui est à risque de carence en bêta-alanine ?\nLes athlètes d'endurance ont-ils besoin de plus de bêta-alanine ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Data+Warehousing&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en bêta-alanine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de test spécifique; une évaluation des symptômes et des apports alimentaires est nécessaire." } }, { "@type": "Question", "name": "Quels tests peuvent évaluer les niveaux de bêta-alanine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses sanguines peuvent mesurer les niveaux d'acides aminés, y compris la bêta-alanine." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une supplémentation excessive en bêta-alanine ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une supplémentation excessive peut provoquer des picotements, des démangeaisons ou des rougeurs." } }, { "@type": "Question", "name": "La bêta-alanine cause-t-elle des effets secondaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des picotements peuvent survenir, mais ils sont généralement bénins." } }, { "@type": "Question", "name": "Comment prévenir une carence en bêta-alanine ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée incluant des sources de protéines peut prévenir une carence." } }, { "@type": "Question", "name": "Les sportifs doivent-ils se supplémenter en bêta-alanine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les sportifs peuvent bénéficier d'une supplémentation pour améliorer leur endurance et performance." } }, { "@type": "Question", "name": "La bêta-alanine est-elle utilisée pour traiter des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle n'est pas un traitement médical, mais un complément pour améliorer la performance sportive." } }, { "@type": "Question", "name": "Comment la bêta-alanine améliore-t-elle la performance ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle augmente les niveaux de carnosine dans les muscles, retardant la fatigue lors d'exercices intenses." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une surconsommation ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des troubles gastro-intestinaux et des picotements." } }, { "@type": "Question", "name": "La bêta-alanine peut-elle interagir avec d'autres médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des interactions sont possibles; il est conseillé de consulter un professionnel de santé." } }, { "@type": "Question", "name": "Qui est à risque de carence en bêta-alanine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant une alimentation pauvre en protéines ou végétalienne peuvent être à risque." } }, { "@type": "Question", "name": "Les athlètes d'endurance ont-ils besoin de plus de bêta-alanine ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent avoir besoin de plus de bêta-alanine pour améliorer leur performance et récupération." } } ] } ] }

Sources (10000 au total)

FHIR-Ontop-OMOP: Building clinical knowledge graphs in FHIR RDF with the OMOP Common data Model.

Knowledge graphs (KGs) play a key role to enable explainable artificial intelligence (AI) applications in healthcare. Constructing clinical knowledge graphs (CKGs) against heterogeneous electronic hea... To develop and evaluate methods and tools that expose the OMOP CDM-based clinical data repositories into virtual clinical KGs that are compliant with FHIR Resource Description Framework (RDF) specific... We developed a system called FHIR-Ontop-OMOP to generate virtual clinical KGs from the OMOP relational databases. We leveraged an OMOP CDM-based Medical Information Mart for Intensive Care (MIMIC-III)... A beta version of the system has been released. A total of more than 100 data element mappings from 11 OMOP CDM clinical data, health system and vocabulary tables were implemented in the system, cover... The FHIR-Ontop-OMOP system can expose OMOP database as a FHIR-compliant RDF graph. It provides a meaningful use case demonstrating the potentials that can be enabled by the interoperability between FH...

A Clinical Data Warehouse Analysis of Risk Factors for Inpatient Falls in a Tertiary Hospital: A Case-Control Study.

The aims of the study are to identify fall risk factors and to establish automatic risk assessments based on clinical data from electronic medical records of hospitalized patients.... In this retrospective case-control study, we reviewed the electronic medical records of 1454 patients (292 and 1162 patients in the fall and nonfall groups, respectively) who were hospitalized at a 18... Overall, 65 risk factors, including low body mass index, low blood pressure, low albumin levels, high fasting blood sugar level, low red blood cell counts, and high potassium levels, that significantl... Fall risk factors identified via the Clinical Data Warehouse can be used to build an automated detection system to detect fall risk in electronic medical records, enabling nurses to assess the fall ri...

Dental developmental complications in pediatric hematopoietic stem cell transplantation patients: A study using CMC clinical data warehouse.

This study aimed to investigate the prevalence and extent of dental developmental complications in patients who have undergone pediatric hematopoietic stem cell transplantation (SCT) and identify the ... We retrospectively investigated the clinical data warehouse of the Catholic Medical Center information system for identifying patients who: 1) visited the Department of Pediatrics between 2009 and 201... All 153 patients had at least one dental anomaly. When grouped according to the age at initial chemotherapy (≤ 2.5; 2.6-5.0; 5.1-7.5; > 7.5 years), the prevalence of agenesis showed statistically sign... The age at initial chemotherapy may be a critical factor in determining the type, extent, and location of dental complications after SCT. These results suggest that careful dental follow-up and timely...

Leveraging electronic medical records for HIV testing, care, and treatment programming in Kenya-the national data warehouse project.

Aggregate electronic data repositories and population-level cross-sectional surveys play a critical role in HIV programme monitoring and surveillance for data-driven decision-making. However, these da... Health information systems in Kenya have evolved from simple paper records to web-based EMRs with features that support data transmission to the NDW. The NDW design includes four layers: data warehous... The NDW presents opportunities for individual-level HIV programme monitoring and surveillance because of its longitudinal design and its ability to respond to public health priorities in real-time. A ...

Modeling and integrating interactions involving the CYP450 enzyme system in a multi-terminology server: Contribution to information extraction from a clinical data warehouse.

The cytochrome P450 (CYP450) enzyme system is involved in the metabolism of certain drugs and is responsible for most drug interactions. These interactions result in either an enzymatic inhibition or ... The objective of this study is to provide a structured data-source of interactions involving the CYP450 enzyme system. These interactions are aimed to be integrated in the cross-lingual multi-terminol... A selection and curation of drug components (DCs) that share a relationship with the CYP450 system was performed from several international data sources. The DCs were linked according to the type of r... A total of 776 DCs are associated by a new interaction relationship, integrated in HeTOP, by 14 enzymes. These are CYP450 1A2, 2A6, 2B6, 2C8, 2C9, 2C18, 2C19, 2D6, 2E1, 3A4, 3A7, 11B1,11B2 mitochondri... The queries submitted to the CDW EDSaN allowed to highlight the most prescribed molecules simultaneously and potentially responsible for cytochromic interactions. In a second step, it would be interes... The HeTOP server contains a non-negligible number of relationships between drug components and CYP450 from multiple reference sources. These data allow us to query our Clinical Data Warehouse to highl...